
Scripps Research Institute Scientists Develop New Technique to Selectively Dampen Harmful Immune Responses The Findings Could Lead to Treatments to Help Hemophiliacs and Other Patients
LA JOLLA, CA June 3, 2013 The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.
As a proof of principle, the study, reported online ahead of print on June 3, 2013, by the Journal of Clinical Investigation, focused on a problem faced by some hemophiliacs rejection of a therapeutic replacement blood clotting protein.
One of the most common forms of hemophilia, hemophilia A afflicts patients who don't have enough of a critical blood clotting protein called Factor VIII. This deficiency can lead to potentially fatal, uncontrolled bleeding. Patients can take replacement Factor VIII as a biotherapeutic, but for about 20-30 percent of them, this is ineffective because their own immune systems attack the Factor VIII.
Current methods to thwart these unwanted immune attacks have severe drawbacks. One method aimed at reversing rejection of Factor VIII has been to give patients very large doses of the protein. But the treatment takes years and is prohibitively expensive. Other techniques, often used for transplant and autoimmune patients, involve taking drugs that broadly compromise the immune system.
In contrast, the new technique from TSRI selectively disables immune cells responsible for Factor VIII rejection, while leaving the rest of the immune system intact.
Harnessing B-Cells
In developing the new method, the scientists, led by James Paulson, chair of TSRI's Department of Cell and Molecular Biology, exploited their knowledge of specialized cells of the immune system.
Both wanted and unwanted immune responses revolve around a few key components. An antigen anything that the immune system detects as a problem prompts the body to produce antibodies that will neutralize and destroy the antigen. B-cells, a type of white blood cell, are the source of these antibodies after coming in contact with specific antigens. The body has millions upon millions of different types of B-cells, each recognizing different antigens.
In addition to their role as antibody producers, B-cells also have receptors on their surfaces that recognize certain naturally occurring molecules that, when bound to the B-cells, initiate their destruction. This process, known as apoptosis, is part of a complex balancing act that allows the immune system to get rid of unneeded cells.
It's this mechanism of cell death that the team is putting to use. The researchers had been working with a specific glycan (type of sugar) that binds to a key B-cell receptor, called CD22, involved in suppressing B-cell activation and apoptosis. An earlier study in collaboration with Professor David Nemazee at TSRI showed potential for causing apoptosis of B-cells with a conjugate of the glycan to small molecule antigens (haptens), but the method had not been applied to protein antigens.
After we started, we realized the opportunity to exploit the receptor's natural function in ways that might be medically relevant, said Paulson.
Preventing Misguided Attacks
To explore the idea, the Paulson group worked with mice genetically altered to lack Factor VIII, which serve as a good model for hemophilia A.
Matthew Macauley, a senior research associate in Paulson's group, and colleagues treated the animals with tiny nanoparticles that included both Factor VIII and the glycan that binds with CD22. They found this combination selectively induce apoptosis in the B-cells that recognize Factor VIII. In this way, mice that had become tolerized to Factor VIII could be successfully treated with therapeutic Factor VIII to prevent bleeding.
By eliminating only these troublesome B-cells while leaving the vast majority of the B-cells intact, the researchers were able to prevent Factor VIII rejection without any negative side effects to the immune system.
We're just taking advantage of a natural mechanism, said Macauley.
The team also conducted experiments that showed the technique prevented an unwanted immune response in mice for several months and may, under some circumstances, even lead to permanent tolerance. This would be a huge benefit if the technique can eventually be applied to humans.
One promising aspect of the new method is that the scaffold used to deliver the necessary components, called liposomal nanoparticles, is already approved by the Federal Drug Administration for other uses. This means that eventual human testing could be vastly simplified. Several pharmaceutical companies have already expressed interest in the technique.
Future Research
In future studies, Paulson, Macauley and colleagues hope to extend the work, answering questions such as: Can the technique be adapted for use on individuals who have already been exposed to Factor VIII and whose memory B-cells have become involved in rejecting the drug? Can the researchers induce tolerance to the multiple antigens on transplanted organs that can lead to organ rejection? Is the technique applicable to more complicated conditions such as allergies and autoimmune diseases such as multiple sclerosis?
We know that the issues are more complex, said Paulson, But our technique, in combination with others, might work to address them.
In addition to Paulson and Macauley, authors on the paper, titled CD22 induced B-cell tolerance prevents inhibitory antibodies to FVIII, are Fabian P
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
16/11/2026
The ESPN Edge Innovation Conference once again gave key ESPN technology partners as a chance to take to the stage and discuss the future of sports fan experienc...
16/11/2026
As rights holders rethink who tells their stories and where, IMG is preparing th...
16/11/2026
From the sidelines, sonic savants advocate for greater emphasis on sound as sports and entertainment increasingly merge
SVG Live!, a one-day event on Nov. 10 i...
16/11/2026
Deal combines Yamaha's audio technology with Disguise's visual-productio...
16/11/2026
Creative effects designed to encourage experimentation
Berry Effects is the brainchild of Abe and Ralph, a pair of multi-instrumentalists and audio engineer...
16/11/2026
Physics-based synth gets first major update
Anukari have just released a new version of their innovative physics-based software synth, marking the instrumen...
16/11/2026
Both versions kitted out with new tools & improvements
Hit'n'Mix have just launched the latest major version of their innovative DAW software, with ...
16/11/2026
Dynamic bands, unmasking features & new stereo tools
Launched in 2021, Eventide's SplitEQ plug-in introduced an interesting new approach to EQ, with the...
16/11/2026
Rohde & Schwarz Japan demonstrates multi-vendor ASA-ML communication with high p...
16/11/2026
November 16, 2026
Hitachi system enables proton beams to be delivered from 360 degrees around the patient, expanding treatment capacity and supporting more pre...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Hiltron Communications has received a repeat order from one of Europes longest established communications satellite operators. Central to this project is a Hilt...
16/11/2026
Fabric Insights and Fonn Group today announce a partnership to connect editorial planning and media operations across their complementary product portfolios.
...
16/11/2026
Density 1.0 brings a complete color grading workflow to Final Cut Pro
Brie Clayton November 16, 2026
0 Comments
Filmmaker Pascal Basel's plugin pr...
16/11/2026
Berklee Students to Perform at Boston's CITGO Sign Relighting Kuper Walker, Ollie Mann, and dreamcorp. will perform at the free public celebration in Kenm...
16/11/2026
The Hollywood Reporter Names Berklee Among World's Best Music Schools The annual list spotlights Berklee's screen scoring programs and new master'...
16/11/2026
Five years ago, Lightware launched the original Taurus UCX with a clear vision: USB-C would become the central connection in meeting rooms. The goal was simple:...
16/11/2026
Sonniss: bundles over 80% below their libraries' prices, plus up to 60% off ...
16/11/2026
Singaporean Comedy Luck My Life Shot with Blackmagic URSA Cine 17K 65
Brie Clayton November 16, 2026
0 Comments
Blackmagic PYXIS 12K and DaVinci Resol...
16/11/2026
Images available HERE
UKTV has announced Fleet Street (6x60'), a new period crime drama from Miss Scarlet creators Rachael New and Ben Edwards, coming to f...
16/11/2026
November 16th, 2026
TRIBECA FESTIVAL LISBOA UNVEILS 2026 FILM LINEUP AND TALE...
16/11/2026
From Graham Norton to Olivia Attwood and Joe Marler, a new collection of hit vid...
16/11/2026
As countries gather to discuss climate targets at COP 31 this week, one question that is at the heart of debates is how to measure the environmental impact of t...
16/11/2026
Announced today at SC26, NVIDIA Rubin HPC is a new GPU in the NVIDIA Vera Rubin ...
16/11/2026
This week at SC26, NVIDIA is marking two decades of CUDA by honoring the researchers, developers and engineers who helped make GPU computing a foundation for mo...
16/11/2026
With expanded NVIDIA CUDA-X libraries, including cuPhoton, cuPotential and cuSpa, researchers can sift through vast amounts of data to accelerate research, from...
16/11/2026
In its MLPerf benchmarks debut, with results released today, the NVIDIA Vera Rub...
16/11/2026
Quantum processor deployments at supercomputing centers have grown nearly sevenfold over the past five years, with nearly 30 supercomputing centers around the w...
16/11/2026
To train an AI model, thousands of GPUs have to work together, requiring a network that's fast, efficient and resilient.
Lambda is tackling the network pie...
15/11/2026
Mixers, interfaces & DAW controller receive new firmware
Yamaha have just launched a trio of firmware updates that bring some powerful new functionality to ...
15/11/2026
Can VideoProc AI Really Reduce Noise and Enhance Blurry, Old Footage? Real-World...
15/11/2026
Over two days at COEX, more than 2,000 attendees converged for AI Day Seoul, bri...
14/11/2026
Longtime MLB Network employee David Maybrown passed away Thursday at the age of 57. David joined MLB Network in 2009 shortly after its launch, beginning as an i...
14/11/2026
Modular innovators introduce two guitar-based products
ADDAC System's recently introduced Four String Series makes it possible to integrate physical str...
14/11/2026
Marcelo Dai's Live Session Captured with URSA Cine Immersive
Brie Clayton November 14, 2026
0 Comments
Artist takes viewers on an immersive journe...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Newest Lenses, Horizon Anamorphic Seminar & Guided Lens Character Experience Highlight Creative Possibilities
At the 2026 Toru CAMERIMAGE Film Festival, ZEISS...
14/11/2026
Sonnet Announces Black Friday Sale on Select Products
Brie Clayton November 14, 2026
0 Comments
WHAT: Sonnet Technologies is having a sale on a select...
14/11/2026
Berklee Alumni Shine at the 2026 Latin Grammy Awards This year's winners included songwriters, engineers, and performers who contributed to acclaimed reco...
13/11/2026
The UIM E1 Series wraps its third season this week with the Bombay Sapphire E1 Miami GP, Nov. 11-14, on Biscayne Bay at the Miami Seaplane Base on Watson Island...
13/11/2026
In-venue and creative video staffers at the professional and collegiate level ha...